We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mosaic Biosciences Unveils Biostimulant Product Neptunion in China
Read MoreHide Full Article
The Mosaic Company (MOS - Free Report) recently announced the launch of its newest biostimulant product, Neptunion, in China. MOS has been redefining growth with its new product launch that is expected to help crops address abiotic pressures such as drought, salinity and heat by adding stress-resistant properties into water-soluble fertilizers.
MOS Biosciences’product line offers sustainable ag technology to provide farmers with solutions to improve yields while minimizing environmental impacts. Neptunion will play a crucial role in maximizing productivity and advancing MOS Biosciences’ business. Neptunion is also undergoing the registration process in India and Brazil.
MOS stock has gained 9.5% over the past year compared with the industry’s 9.4% growth.
Image Source: Zacks Investment Research
The company expects sales volumes for the Potash segment to be between 2.3 million tons and 2.5 million tons in the second quarter. For the Phosphate division, sales volumes are projected to be 1.7-1.9 million tons, reflecting strong demand globally.
MOS also expects sales volumes for the second quarter to be around 30% higher than the first quarter for the Mosaic Fertilizantes unit. Distribution margin is forecast to be in the annual normalized $30-$40 per ton range.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, while missing the rest.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have soared 16% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest, with the average surprise being roughly 21.70%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Mosaic Biosciences Unveils Biostimulant Product Neptunion in China
The Mosaic Company (MOS - Free Report) recently announced the launch of its newest biostimulant product, Neptunion, in China. MOS has been redefining growth with its new product launch that is expected to help crops address abiotic pressures such as drought, salinity and heat by adding stress-resistant properties into water-soluble fertilizers.
MOS Biosciences’product line offers sustainable ag technology to provide farmers with solutions to improve yields while minimizing environmental impacts. Neptunion will play a crucial role in maximizing productivity and advancing MOS Biosciences’ business. Neptunion is also undergoing the registration process in India and Brazil.
MOS stock has gained 9.5% over the past year compared with the industry’s 9.4% growth.
Image Source: Zacks Investment Research
The company expects sales volumes for the Potash segment to be between 2.3 million tons and 2.5 million tons in the second quarter. For the Phosphate division, sales volumes are projected to be 1.7-1.9 million tons, reflecting strong demand globally.
MOS also expects sales volumes for the second quarter to be around 30% higher than the first quarter for the Mosaic Fertilizantes unit. Distribution margin is forecast to be in the annual normalized $30-$40 per ton range.
MOS’ Zacks Rank and Other Key Picks
MOS currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Idaho Strategic Resources, Inc. (IDR - Free Report) . While AKZOY sports a Zacks Rank #1 (Strong Buy), NEM and IDR currently carry a Zacks Rank #2 each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, while missing the rest.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have soared 16% in the past year.
The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest, with the average surprise being roughly 21.70%.